Response to "Post-marketing strategies for medicine''

被引:0
|
作者
Goldhammer, A. [1 ]
机构
[1] Pharmaceut Res & Manufacturers Amer, Washington, DC USA
关键词
D O I
10.1038/sj.clpt.6100444
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [31] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [33] POST-MARKETING SURVEILLANCE OF MEDICINES IN THE UK
    GRIFFIN, JP
    BAKER, R
    PHARMACY INTERNATIONAL, 1981, 2 (09): : 203 - 209
  • [34] Sodium Oxybate Post-Marketing Surveillance
    Feldman, Neil T.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2011, 7 (04): : 417 - 417
  • [35] Post-marketing stability surveillance: Amoxicillin
    Naidoo, K. K.
    Nompuku, P.
    Mkalali, S. N.
    Shabangu, K.
    Nkabinde, L.
    Singh, V
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (06) : 14 - +
  • [36] POST-MARKETING SURVEILLANCE OF OFLOXACIN IN JAPAN
    YAMADA, A
    NAKAMURA, S
    TAKAHASHI, K
    SAWADA, M
    OKADA, S
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1409 - S1409
  • [37] A post-marketing observational monocentric study
    Moiola, L.
    Pisa, M.
    Sangalli, F.
    Di Cristinzi, M.
    Costa, G. Dalla
    Radaelli, M.
    Esposito, F.
    Boneschi, F. G. Martinelli
    Colombo, B.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 319 - 319
  • [38] Methodological Approaches to Developing and Establishing the Body of Evidence on Post-marketing Chinese Medicine Safety
    廖星
    Nicola Robinson
    Chinese Journal of Integrative Medicine, 2013, (07) : 494 - 497
  • [39] FDA should tighten post-marketing surveillance of prescription drugs, says Institute of Medicine
    Roehr, Bob
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [40] Methodological Approaches to Developing and Establishing the Body of Evidence on Post-marketing Chinese Medicine Safety
    廖星
    Nicola Robinson
    Chinese Journal of Integrative Medicine, 2013, 19 (07) : 494 - 497